Regulating the fate of tumor-associated macrophages
Cancer Cell · 2025-07 · 43 (7) · 1191-1193
DOI: 10.1016/j.ccell.2025.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-07. Verfasst von Elina Timosenko und 1 weiteren Autor:innen. Beteiligte Einrichtung: ICC, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Neoplasms, Macrophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) are key players in tumor progression, yet their role in this process remains only partially understood. In this issue of Cancer Cell, Sheban et al. demonstrate that zinc finger E-box-binding homeobox 2 (ZEB2) acts as a master regulator that reprograms TAMs toward a pro-tumor phenotype and that therapeutic targeting of ZEB2 exhibits anti-tumor activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ICC, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK.
- ICC, Oncology R&D, AstraZeneca, Gaithersburg, MD 20878, USA. Electronic address: dmitry.gabrilovich@astrazeneca.com.
Zitieren
APA
Timosenko, E., & Gabrilovich, D. I. (2025). Regulating the fate of tumor-associated macrophages. Cancer Cell, 43(7), 1191-1193. https://doi.org/10.1016/j.ccell.2025.04.006
Vancouver
Timosenko E, Gabrilovich DI. Regulating the fate of tumor-associated macrophages. Cancer Cell. 2025;43(7):1191-1193. doi:10.1016/j.ccell.2025.04.006
BibTeX
@article{Timosenko2025,
author = {Timosenko, Elina and Gabrilovich, Dmitry I},
title = {Regulating the fate of tumor-associated macrophages},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {7},
pages = {1191--1193},
doi = {10.1016/j.ccell.2025.04.006}
}
EUVIMED